Plasma Levels of GDF-9 and GDF-15 in Patients With Polycystic Ovary Syndrome.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01644305
Verified July 2012 by Ankara Education and Research Hospital. Recruitment status was: Active, not recruiting
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
25 Years to 35 Years (Adult)
Sexes Eligible for Study:
Hospital Endocrinology Outpatient Clinic
Female patients at ages 25-35 diagnosed with polycystic ovarian syndrome and idiopathic hirsutism
acute infectious disease, a thyroid, pituitary, nutritional, inflammatory, hepatic, renal, or neoplastic disorder; history of cardiovascular disease or pulmonary embolism; a family history of coronary artery disease; smoking history; hypertension; diabetes mellitus; use of oral contraceptives, anti-androgens and drugs known to interfere with cytokine release, such as corticosteroids, immunosuppressors, or nonsteroidal antiinflammatory drugs.
any medication known to affect hormonal or metabolic parameters.